Minerva Neurosciences, Inc. (NERV) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Minerva Neurosciences, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -0.12x | 11.68x | -1.33x | -0.26x | -0.69x | 49.22x |
| P/B Ratio | -0.24x | -0.65x | -1.41x | -0.42x | 4.29x | 1.81x |
| P/S Ratio | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 2.32x |
| Profitability | ||||||
| Gross Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 100.0% |
| Operating Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 4.5% |
| Net Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 4.7% |
| EBITDA Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 5.1% |
| Liquidity | ||||||
| Current Ratio | 36.29x | 7.85x | 12.57x | 29.15x | 22.07x | 8.68x |
| Quick Ratio | 36.29x | 7.85x | 12.57x | 29.15x | 22.07x | 8.68x |
| Leverage | ||||||
| Debt/Equity | -0.46x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
YoY = year-over-year change. Source: FMP..